LPA and atherosclerosis: In the Copenhagen General Population Study, the 5-year risk for recurrent major adverse cardiovascular events (MACEs) in subjects with pre-existing ASCVD was higher for Lp(a) levels ≥50 mg/dL, independently of LDL plasma levels [69].